Fortress Biotech (FBIO) Management Meeting Reinforces Upside Thesis - Roth Capital
Tweet Send to a Friend
Roth Capital analyst Scott Henry reiterated a Buy rating and $4.00 price target on Fortress Biotech (NASDAQ: FBIO) after meeting ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
